pharmaceuticals

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Andrea N. Flynn -- Vice President, Head, Investor…

Perrigo Co PLC (NYSE:PRGO) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations…

Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile,…

Zoetis Inc (NYSE:ZTS) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Steve Frank -- Vice President of Investor Relations Kristin…

The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant…

Eli Lilly and Company (NYSE:LLY) Q3 2022 Earnings Call dated Nov. 01, 2022. Corporate Participants: Joe Fletcher -- Senior Vice President, Investor…

Shares of Pfizer Inc. (NYSE: PFE) were up 3% on Tuesday after the company beat estimates for the third quarter…

Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The…

Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net…

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while…

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced…

Pharma giant Biogen Inc. (NASDAQ: BIIB) on Tuesday announced financial results for the third quarter of 2022, reporting a double-digit…

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in…

Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic…

Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase…

Johnson & Johnson (NYSE: JNJ) has stayed largely unaffected by the COVID crisis and macroeconomic headwinds so far, which allowed…

Cannabis company Tilray (NASDAQ: TLRY) has announced financial results for the first quarter of 2023, reporting a wider net loss…

AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase…

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big…

Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent…